OnShift is a leading provider of integrated employee scheduling and communications technology with an aim to optimize labor utilization and control labor costs for employers with shift-based workforces. OnShift’s flagship product is an intuitive, web-based application that combines staff scheduling, work requirements, employee qualifications, business rules, and communications into a highly automated staff management system. Their focus is the senior-living industry, providing OnShift with a breadth of knowledge and understanding of this area, specifically on how providers work day-in and day-out and on the effects of industry regulations and issues. OnShift has received investment from the North Coast Angel Fund and the Jumpstart Evergreen, Focus, Next Funds, and Flashline Partners.
Nine Iron Innovations provided an automated mobile video monitoring system for golf course contests and events. The company’s product portfolio included VerishotMobile, a golf shot video monitoring, contest, and marketing program for golf courses, event managers, golf management organizations, and independent representatives. It also included Sharegolf.com, a social networking site that connected golf courses and golfers, and allowed them to view and share videos of their swings with other members. Nine Iron Innovations has received investment from the North Coast Angel Fund and the Jumpstart Fund.
Neuros Medical, a Cleveland-based neurostimulation company, is focused on developing neurostimulation therapies for unmet needs to patients worldwide. The company’s platform technology, Electrical Nerve Block, works to eliminate chronic pain and spasticity in a variety of applications, including neuroma/residual limb pain, chronic post surgical pain, and chronic migraine. Neuros has received investment from the North Coast Angel Fund and the Jumpstart Evergreen, Focus, and Next Funds.
nChannel, based in Columbus, offers a highly flexible, multi-channel, financial management platform for small and medium-sized merchants. This capability enables companies to integrate and sync many of their disparate but essential systems, such as QuickBooks, e-commerce websites, inventory management, CRM solutions, etc. In turn, companies are able to increase production through multiple channels, reduce operating costs, and maintain a consistent customer experience. Current customers range in size from independent, single store merchants to 100+ store chains. Major players in the e-commerce industry have shown a keen interest in nChannel. nChannel has received investment from the North Coast Angel Fund.
NanoVision Diagnostics is commercializing a breakthrough cancer technology that can sooner detect and more accurately predict the risk of progression through the optical analysis of a standard biopsy slide. Their patented microscope has 1000x better sensitivity than an optical microscope, enabling it to detect molecular scale changes that are not visible through conventional pathology. Molecular changes manifest prior to cellular changes, allowing earlier and more accurate detection. The company is initially focused on the detection and prognosis of breast cancer, with plans to expand to the study of multiple cancer strains in the future. NanoVision Diagnostics has received investment from the North Coast Angel Fund.
I2C Technologies provides advanced IP based video surveillance solutions for businesses and individuals. Designed by both IT experts and law enforcement agents, I2C’s Video Management Software (VMS) has created the most unique video surveillance platform on the market today. I2C’s solutions are used by many municipalities, utilities, and law enforcement agencies. I2C Technologies has received investment from the North Coast Angel Fund.
Great Lakes Pharmaceuticals, Inc. is a clinical stage company focused on developing and commercializing products that prevent infections associated with indwelling catheters. Their first product, B-Lock™, is an anticoagulant catheter lock solution that works against the bacterial and fungal microorganisms known to form biofilm structures in catheters. Biofilm-related infections are the 8th leading cause of death in the United States. Headquartered in Concord, OH with offices in San Diego, CA, Great Lakes Pharmaceuticals assembled teams of experienced and distinguished scientists, clinicians, and managers to assure a smooth development as well as the commercialization of innovative, effective treatments of microbial infections in clinical and outpatient settings. Great Lakes Pharmaceuticals has received investment from the North Coast Angel Fund and the Jumpstart Evergreen, Next, and Focus funds.
GenomOncology is in the personalized medicine space with a proprietary technology platform to rapidly analyze sequenced genomic data for use in cancer treatment. The platform enables users to browse, filter, and map variations at many different levels to discover the genetic mutations that are unique to the tumor. From this analysis, the company generates a customizable report, including findings and clinical recommendations based on the observed actionable mutations in the tumor genome. Considering cancer is a disease of genetic mutation, this type of personalized approach represents the future of oncology. GenomOncology has received investment from the North Coast Angel Fund and the Jumpstart Evergreen, Next, and Focus funds.
Exacter, Inc. is a Columbus-based diagnostic service provider that enables electric utilities to proactively avoid power outages. Distribution reliability is the top industry problem. Their service is marketed as Intelligence-Based Preventive Maintenance™ which is based upon mobile EXACTER™ surveying instrumentation units connected to a web portal via cellular communications. EXACTER units require no new rolling stock, new personnel, training, or capital expenditures for the customer. The utility maintenance dispatchers use the web portal to access data that locates failing equipment and its fault severity — Maintenance Merit™ — in a timely manner for the purpose of setting priorities for work crews to replace or repair failing equipment. Exacter has received investment from the North Coast Angel Fund.
Cryothermic Systems (formerly known as LifeCore Technologies) offers the Excel ® Cryo Cooling System for immediate and selective cooling of the brain after cardiac arrest, stroke, or traumatic brain injury. A 2009 Cath Lab Digest study reported that, “for every hour to first cooling, the relative hazard of death increases 29%.” The coolant and collar system was recently honored for its innovative design and ease of use by EMS Pro Magazine and by the Journal of Emergency Medical Services. The company is working to accelerate adoption by hospitals and EMS services. Cryothermic Systems has received funding from the North Coast Angel Fund and the Jumpstart Next, Evergreen, and Focus Funds.